Erin Xie
AA
12 Years of experience
Focus on high-quality firms at attractive prices
Current firm: Blackrock
Professional background
Joined SSRM, whicn mergered with BlacRcok, in 2001. Research Associate covering the pharma industry, Bernstein.
Educational background
MBA, Massachusetts Institute of Technology Sloan School of Management. PhD in Biochemistry, Unviersity of California. BSc in Chemistry, Beijing University.
Performance
12.81%
Manager Annualised Return Since Inception
10.78%
Benchmark Annualised Return since Inception
Manager Performance
Manager
Benchmark
Dif.
Inception*
12.81%
10.78%
2.03%
5Y
8.79%
7.7%
1.09%
*Inception date: 4/1/2011
Data as at 30 September 2022.
Risk Statement / Disclaimer: Data is collected by Tenvalue. Care has been taken to ensure that the information is accurate, but Tenvalue neither warrants nor guarantees the contents, nor does it accept any responsibility for errors, inaccuracies or omissions herein. Past performance does not necessarily indicate future returns and should not be the sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise. This listing is for informational purposes only. You should not construe any of this material as investment, financial or other advice.
BGF World Healthscience
Value investing using fundamental analysis
BenchmarkBGF World Healthcare
ClassClass D2
ISINLU0827889485
AUM12,936,135,482.55 €
Ongoing Charges1.06%